ArticleMedical oncology (Northwood, London, England)2015

Efficacy and tolerability of crizotinib in the treatment of ALK-positive, advanced non-small cell lung cancer in Chinese patients.

Shaohua Cui et al.PubMed ↗Publisher ↗

No numbers read from the abstract.